| P50 | author | Tomomi Kimura | Q87782591 |
| P2093 | author name string | Masahiko Kobayashi | |
| | Shinji Takahashi | |
| | Yasuaki Takeda | |
| | Kazuhito Shiosakai | |
| | Motonobu Sakaguchi | |
| P2860 | cites work | Impact of regulatory safety warnings on the use of antidepressants among children and adolescents in Finland | Q43087546 |
| | Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus | Q43120554 |
| | Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients | Q43140345 |
| | Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide | Q43834028 |
| | Echocardiography for the detection of valvulopathy associated with the use of ergot-derived dopamine agonists in patients with Parkinson's disease | Q44130052 |
| | Impact of cisapride label changes on codispensing of contraindicated medications. | Q44481515 |
| | Impact of safety warnings on drug utilization: marketplace life span of cisapride and troglitazone | Q45037773 |
| | Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus | Q46177613 |
| | Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes | Q46953451 |
| | Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study. | Q51371877 |
| | Segmented regression analysis of interrupted time series studies in medication use research | Q74601008 |
| | Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes | Q24642503 |
| | Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study | Q28244610 |
| | The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes | Q28273497 |
| | Oseltamivir prescription and regulatory actions vis-à-vis abnormal behavior risk in Japan: drug utilization study using a nationwide pharmacy database | Q28478300 |
| | A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin | Q29397208 |
| | Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study | Q34044817 |
| | Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants | Q35896311 |
| | Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program | Q35951667 |
| | Antidepressants in children and adolescents--changes in utilisation after safety warnings | Q36792735 |
| | Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events | Q37240896 |
| | Adherence to recommended dosing and monitoring for mitoxantrone in patients with multiple sclerosis: a healthcare claims database study supplemented with medical records--the RETRO study | Q37718137 |
| | The impact in Japan of regulatory action on prescribing of dopamine receptor agonists: analysis of a claims database between 2005 and 2008. | Q37854582 |
| | Dipeptidyl peptidase-4 inhibitors: 3 years of experience. | Q37983085 |
| | Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial | Q42999172 |
| | Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients | Q43013436 |
| | Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus | Q43032909 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P304 | page(s) | 479-493 | |
| P577 | publication date | 2012-09-19 | |
| P1433 | published in | Pharmaceutics | Q27723332 |
| P1476 | title | Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan | |
| P478 | volume | 4 | |